Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion
touchPANEL DISCUSSION for touchNEUROLOGY
Listen as three experts in spinal muscular atrophy (SMA) discuss factors influencing treatment decision-making with approved SMA therapies using patient case studies.
The experts
Prof. Eugenio Mercuri – Policlinico Universitario Agostino Gemelli, Rome, Italy
Prof. Nathalie Goemans – UZ Leuven, Leuven, Belgium
Prof. Dr. med. Tim Hagenacker – Essen University Hospital, Essen, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Biogen and Novartis Gene Therapies. This activity is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.